ArticlePLOS global public health2025
Intimate partner violence during pregnancy and its association with pregnancy and childbirth complications: A prospective cohort study.
Article in PLOS global public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Association of adverse pregnancy outcomes and intimate partner violence survivorship: a cross-sectional survey.Frontiers in global women's health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intimate partner violence (IPV) during pregnancy increases the risk of adverse outcomes for both the woman and foetus. However, there is limited research on its scope and impact in many sub-Saharan African countries. In this study, we investigated the effects of IPV during pregnancy on pregnancy and childbirth complications in Ethiopia. Prospective, longitudinal data from the Performance Monitoring for Action Ethiopia (PMA Ethiopia) Cohort 1 study covering a sample of 2635 women followed up until one year postpartum was used for analysis. Information on IPV during pregnancy and obstetric complications were collected from women at six-week follow-up visits. Multivariable log-binomial regression estimated the risk of antepartum, intrapartum, and postpartum complications associated with IPV of any type, physical IPV and sexual IPV during pregnancy. The prevalence of any IPV type was 13%, only physical IPV was 4.6%, and only sexual IPV was 7.1%. Physical IPV was associated with an increased risk of worsening vision at night during pregnancy (adjusted relative risk [aRR]=2.47, 95% Confidence Interval [95%CI]=1.46 - 4.77), intrapartum haemorrhage (aRR=1.65, 95%CI=1.11 - 2.46), and intrapartum convulsion (aRR=1.98, 95%CI=1.34 - 2.94). Sexual IPV was associated with increased risk for antepartum convulsion (aRR=1.93, 95%CI=1.07 - 3.48), leaked/ruptured membrane (aRR=2.86, 95%CI=1.59 - 5.14), malpresentation (aRR=2.37, 95%CI=1.17 - 4.80), intrapartum convulsions (aRR=1.86, 95%CI=1.16 - 2.98), postpartum haemorrhage (aRR=1.68, 95%CI=1.18 - 2.40) and fever with foul discharge (aRR=2.03, 95%CI=1.40 - 2.93). Overall, the experience of any IPV type increased the risk for the above in addition to migraine, postpartum convulsion, and abnormal vaginal discharge. There is a need to embed IPV sensitisation campaigns in maternal health policies and interventions and to empower women to report cases for timely intervention.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.